Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Intercept Pharmaceuticals Inc: What Goes Up Must Come Down

Intercept Pharmaceuticals (NASDAQ: ICPT  ) has gone on an unprecedented run. It nearly quadrupled on Thursday before adding another 60% on Friday, to become a two-day six-bagger. This all happened after lead drug candidate OCA had a trial halted because the drug was working so well in patients with NASH, a disease with no approved treatments and a leading cause of liver failure.

However, what goes up must come down -- at least a little.

Shares of Intercept fell about 20% today. This isn't just a story of investors who are taking a cold shower over the weekend and taking profits Monday. Potentially concerning data came out from the company's groundbreaking phase 2 trial, and Intercept's CEO threw a wet blanket on bullish investors by suggesting a partnership.

Watch as Motley Fool health-care analyst David Williamson discusses why the new data raised red flags for investors, why the CEO's comments were poorly received, and why Intercept is such a risky, but potentially incredibly rewarding, stock.

Picks for ultimate growth
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2793734, ~/Articles/ArticleHandler.aspx, 8/31/2015 7:53:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

David Williamson

The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...

Today's Market

updated Moments ago Sponsored by:
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASD 4,776.51 -51.82 -1.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/31/2015 3:59 PM
ICPT $189.76 Up +0.81 +0.43%
Intercept Pharmace… CAPS Rating: **